Profile
LTRN NVO VRTX REGN SGEN ALNY
Company Name Lantern Pharma Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $37.57M $498.51B $122.62B $100.05B $43.15B $36.14B
Employees 0.02K 69.26K 5.40K 13.93K 3.26K 2.10K
CEO Mr. Panna Sharma PH.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
LTRN NVO VRTX REGN SGEN ALNY
Quant Rating Score 2 3 2 4 3 2
Quant Rating Sell Neutral Sell Buy Neutral Sell
Trading
LTRN NVO VRTX REGN SGEN ALNY
Last Close $3.26 $113.24 $475.08 $922.79 $228.74 $281.49
High 52 $10.65 $146.91 $505.78 $1201.76 $228.9 $296.75
Low 52 $2.48 $96.21 $343 $779.89 $211.85 $143.31
Price vs. 52 Week High -69.39 % -22.92 % -6.07 % -23.21 % -0.07 % -5.14 %
Price vs. 52 Week Low 31.45 % 17.7 % 38.51 % 18.32 % 7.97 % 96.42 %
Total Return
LTRN NVO VRTX REGN SGEN ALNY
1 Month Return -13.3 % -4.04 % 1.13 % -11.86 % 0 % 1.97 %
3 Month Return -22.38 % -14.62 % -4.16 % -14.49 % 0 % 18.54 %
6 Month Return -39.52 % -12.36 % 18.14 % 2.14 % 0 % 87.71 %
9 Month Return -22.75 % -1.31 % 9.62 % -2.12 % 0 % 62.8 %
YTD Return -23.83 % 9.46 % 16.76 % 5.07 % 0 % 47.06 %
1 Year Return 31.45 % 17.23 % 31.2 % 18.32 % 7.49 % 85.43 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LTRN NVO VRTX REGN SGEN ALNY
Dividend Yield Percentage (TTM) - 1.28 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -933.58 % 1.26 % -1.96 % 4.72 % -3.35 % 6.97 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.71 % - - - -
Growth
LTRN NVO VRTX REGN SGEN ALNY
Asset Growth -25.82 % 30.35 % 25.23 % 13.23 % -1.21 % 7.99 %
Gross Profit Growth -13.03 % 32.32 % 9.25 % 6.49 % 22.93 % 74.75 %
Revenue Growth - 31.26 % 10.17 % 7.76 % 24.65 % 76.23 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 91.84 % 241.5 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 215.48 % 1865.57 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 494.04 % 1810.11 %
EBIT Growth -23.87 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Net Income Growth -13.31 % 50.71 % 8.96 % -8.87 % 9.51 % 61.08 %
Net Income 3 Yeari Growth Per Share -55.01 % 106.79 % 34.59 % 13.48 % -764.83 % 52.78 %
Net Income 5 Yeari Growth Per Share -430.18 % 133.86 % 70.33 % 74.02 % -276.93 % 53.44 %
Net Income 10 Yeari Growth Per Share -430.18 % 98.61 % 809.6 % 871.12 % -624.16 % -143.14 %
Operating Income Growth -23.87 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Operating Cash Flow Growth (CFG) -12.37 % 38.06 % -14.35 % -8.39 % 9.07 % 119.24 %
Operating 3 Year CFG -45.65 % 118.29 % 9.63 % 76.95 % -148.34 % 115.59 %
Operating 5 Year CFG -547.03 % 163.51 % 174.78 % 125.17 % -195.86 % 114.91 %
Operating 10 Year CFG -547.03 % 150.92 % 6084.35 % 713.56 % -2622.09 % 174.76 %
EPS Growth -13.08 % 52.28 % 8.33 % -8.54 % 10.81 % 62.15 %
EPS Diluted Growth -13.08 % 52.37 % 8.35 % -9.03 % 10.81 % 62.15 %
Book Value Per Share -26.94 % 29 % 25.58 % 15.03 % -9.83 % -35.86 %
Share Holder 3 Year Equity Growth Per Share 19.15 % 75.22 % 104.06 % 137.56 % 33.92 % -119.99 %
Share Holder 5 Year Equity Growth Per Share 11724.89 % 121.9 % 291.14 % 219.1 % 220.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share 11724.89 % 49.62 % 1030.79 % 1286.9 % 691.19 % -140.22 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 343.32 % 4.74 % 44.1 % 0.06 % -23.28 % 103.19 %
Free Cash Flow Growth -12.27 % 9.17 % -16.47 % -17.11 % 3.67 % 106.84 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
LTRN NVO VRTX REGN SGEN ALNY
Gross Profit Margin TTM 47.15 % 84.53 % 86.43 % 86.08 % 75.4 % 87 %
Return on Assets TTM -49.87 % 24.34 % -2.43 % 11.98 % -20.64 % -1.82 %
Return on Equity TTM -46.39 % 87.5 % -2.91 % 16.3 % -28.06 % 47.92 %
Return on Capital Employed TTM -63.07 % 61.51 % -2.36 % 12.08 % -29.5 % 3.47 %
Net Income Per EBT TTM 100 % 79.6 % -228.18 % 94.21 % 101.53 % 118.22 %
EBT Per Ebit TTM 90.82 % 101.17 % -54.74 % 116.55 % 93.47 % -60.11 %
EBIT Per Revenue TTM -7485.66 % 43.26 % -3.8 % 29.18 % -34.37 % 4.38 %
Cash Flow To Debt Ratio TTM -6976.18 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Receivables Turnover TTM - 3.88 6.23 2.36 3.64 7.58
Payables Turnover TTM 0.03 1.34 4.27 3.34 2.52 4.12
Inventory Turnover TTM - 1.1 1.53 0.65 1.07 3.63
Fixed Asset Turnover TTM 99.13 % 234.59 % 583 % 313.27 % 471.71 % 327.68 %
Asset Turnover TTM 0.73 % 69.85 % 51.28 % 37.38 % 63.3 % 58.47 %
Operating Cash Flow Per Share TTM -1.42 25.87 -3.66 37.65 -2.87 2.94
Free Cash Flow Per Share TTM -1.42 14.81 -5.52 29.68 -3.73 2.52
Cash Per Share TTM 309.16 % 1405.52 % 2245.45 % 9080.94 % 657.5 % 2071.01 %
Operating Cash Flow Sales Ratio TTM -5844.28 % 44.7 % -9.14 % 30.18 % -23.48 % 15.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.11 % 57.25 % 151.04 % 78.82 % 129.82 % 85.66 %
Cash Flow Coverage Ratios TTM -6976.18 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Price To Free Cash Flows Ratio TTM -2.46 51.89 -86 31.18 -61.54 113.33
Price To Operating Cash Flows Ratio TTM -2.46 30.08 -129.89 24.51 -79.67 95.83
Price Cash Flow Ratio TTM -2.46 30.08 -129.89 24.51 -79.67 95.83
Income Statement (TTM)
LTRN NVO VRTX REGN SGEN ALNY
Revenue $0B $232.26B $9.84B $13.12B $1.96B $1.83B
Gross Profit $-0B $196.5B $8.58B $11.3B $1.55B $1.52B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 79.1% 83.02%
EBITDA $-0.02B $112.94B $3.93B $5.13B $-0.62B $-0.23B
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.44B
EPS Diluted -1.47 18.62 13.89 34.77 -3.3 -3.52
Balance Sheet (MRQ)
LTRN NVO VRTX REGN SGEN ALNY
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $2.34B
Total Liabilities $0B $207.93B $5.15B $7.11B $0.87B $4.05B
Total Equity $0.04B $106.56B $17.58B $25.97B $2.8B $-0.22B
Total Investments $0.02B $17.5B $3.45B $13.51B $1.42B $1.68B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $2.68B
Total Assets $0.04B $314.49B $22.73B $33.08B $3.67B $3.83B
Cash Flow Statement (TTM)
LTRN NVO VRTX REGN SGEN ALNY
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.44B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.02B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $0.1B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.96
ABCL AbCellera Biologics Inc. 2.78
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.36
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 3.03
ABSI Absci Corporation 4.14
ABUS Arbutus Biopharma Corporation 3.94
ABVC ABVC BioPharma, Inc. 0.72
ABVX Abivax SA American Depositary Shares 10.49
ACAD ACADIA Pharmaceuticals Inc. 14.77
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.36
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.02
ACHV Achieve Life Sciences, Inc. 4.73
ACIU AC Immune SA 2.97
ACLX Arcellx, Inc. 86.81
ACRV Acrivon Therapeutics, Inc. Common Stock 8.35
ACST Acasti Pharma Inc. 3.37
ETFs With Exposure to LTRN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 286.37
VXF Vanguard Extended Market Index Fund 0 185.69
IWC iShares Micro-Cap ETF 0.00625 126.53
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 99.22
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 99.2
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.72
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.71
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.71
DFAT Dimensional U.S. Targeted Value ETF 0.00009149 55.64
DFAC Dimensional U.S. Core Equity 2 ETF 0.00005097 34.6
VTSAX Vanguard Total Stock Market Index Fund 0 139.31
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 140.89
VITSX Vanguard Total Stock Market Index Fund 0 139.34
DFSU Dimensional US Sustainability Core 1 ETF 0.00050278 37.56
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000170778 98.73
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 140.9
MEDX Horizon Kinetics Medical ETF 0.53 29.56
DCOR Dimensional ETF Trust 0.00000136 63.96
VEMPX Vanguard Extended Market Index InstlPlus 0 347.7
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 261.37
DXUV Dimensional ETF Trust 0.00001826 52.9052
Unlock